When considering the ratios, a significantly lower P-IL10/IL17a-ratio (1.43±0.73 vs.1.89±0.64 pg/mL; p = 0.04) and higher P-M1/M2-ratio (3.86±2.72 vs. 2.21±1.11 pg/mL; p = 0.01) was observed in NASH versus no-NASH patients (Fig 1). This evidence concerns the gene IL17A and metabolic dysfunction-associated steatohepatitis.